|
| |||||||||||||||||||||||||||||||
melanocyte-stimulating hormone was increased by a factor of six as compared with values in controls; there was no other sign of endocrine dysregulation.
|
Arjen F. Nikkels, M.D., Ph.D.
Gérald E. Piérard, M.D., Ph.D.
University of Liège
B-4000 Liège, Belgium
Editor's note: We received 755 responses to the medical mystery. About 43 percent of the respondents said that the woman had alkaptonuric ochronosis. The next most common explanation, suggested by 23 percent of respondents, was that the patient had melanoma. Another common answer, suggested by 22 percent of respondents, was porphyria or porphyria cutanea tarda. Other responses included paroxysmal nocturnal hemoglobinuria and ingestion of arsenic or silver.
| |||||||||||||||||||||||||||||||
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |